[Action of proteinase inhibitors in rats. 3. Influence of leupeptin on the rate of protein synthesis and the intracellular protein degradation by use of a test system including constant infusion of labelled amino acids, estimation of 3-methyl-histidine excretion and a triple-labelling technique].
Male Wistar rats (initial body weight 90 g) were fed ad libitum a whole-egg diet containing 10,5% crude protein. The animals of the experimental group received in each case of 1 mg leupeptin per 100 g of body weight in 12 hrs-intervals by i. p.-injection (3 days of treatment). Control animals got a leupeptin free solution. In addition, lysine dihydrochloride-alpha-15N was applied during the first three days of experiment to all animals and the nitrogen balance was determined. Urine from the N-Balance collection was analysed for 3-methyl-histidine excretion in order to calculate the degradation rate of myofibrillar proteins. On the fourth day the fractional rate of protein synthesis in several organs was estimated using the continuous infusion technique with 14C-leucine and 14C-lysine. The apparent biological half-lives of tissue protein were determined by a triple labelling technique, with (14C)-guanidino-L-arginine, L-5-3H-arginine and 15N-Lysine. The short-term treatment 3 days) with leupeptin did not affect the weight gain, the apparent digestibility of nitrogen and the N-balance. The fractional rate of protein synthesis was highest in the small intestine followed by the large intestine, liver and skeletal muscle and no influence of leupeptin treatment was observed. Furthermore no differences in the degradation rates of myofibrillar proteins between treated and untreated animals were found. The 3-methyl-histidine excretion via urine was 1.44 mg . kg-1 day-1 in both groups corresponding to a fractional rate of degradation of myofibrillar proteins of 2,5% per day. Apparent half-lives of tissue proteins in the small intestine, large intestine and liver, respectively, were shortest when estimated from the decay curves for the 14C-label and longest from the curves for the 15N-label. Leupeptin treatment resulted in prolonged apparent half-lives of the proteins in the large intestine and of the slowly turning over proteins in the liver. However, this effect seems to be caused rather by an increased reutilization of labelled amino acids than by a decreased protein degradation. Before continuing this kind of work the rate of uptake of injected leupeptine into tissues has to be investigated. Studies dealing with the in vivo action of proteinase inhibitors on protein metabolism have to include estimations of N-balance, protein synthesis rate, intracellular degradation rate of proteins as well as amino acid reutilization.
D000596:Amino Acids / Q000378:metabolism*; D002250:Carbon Radioisotopes; D006639:Histidine / Q000031:analogs & derivatives*; D007553:Isotope Labeling; D007700:Kinetics; D007976:Leupeptins / Q000494:pharmacology*; D008762:Methylhistidines / Q000378:metabolism*; D009587:Nitrogen Isotopes; D009842:Oligopeptides / Q000494:pharmacology*; D011480:Protease Inhibitors / Q000494:pharmacology*; D014176:Protein Biosynthesis; D011506:Proteins / Q000378:metabolism*; D014316:Tritium
D000596:Amino Acids; D002250:Carbon Radioisotopes; D007976:Leupeptins; D008762:Methylhistidines; D009587:Nitrogen Isotopes; D009842:Oligopeptides; D011480:Protease Inhibitors; D011506:Proteins; D014316:Tritium; D006639:Histidine
Untersuchungen zur Wirkung von Proteinaseinhibitoren bei Ratten. 39 Mitteilung. Einfluss von Leupeptin auf die Proteinsyntheserate und den intrazellulären Protein abbau unter Anwendung eines Testsystems, das die Dauerinfusion markierter Amino säuren, die Bestimmung der 3-Methylhistidinausscheidung und eine Dreifachmarkierungstechnik einschliesst.